Inventor · disambiguated record
David Gordon Bermudes
Also filed as: BERMUDES DAVID · BERMUDES DAVID G · BERMUDES DAVID GORDON
58 granted patents·9 pending applications·1,670 citations·filing 1996–2022
99Inventor score
Files withBERMUDES DAVID GORDON46VION PHARMACEUTICALS INC9UNIV YALE4AVIEX TECHNOLOGIES LLC2BERMUDES DAVID G2
Top patents by PatentIndex Score
67 records- 0199US11471497B1Copper chelation therapeuticsBERMUDES DAVID GORDON·Filed 2020·Granted Oct 18, 2022·10 cites·20 claims
- 0299US10973908B1Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccineBERMUDES DAVID GORDON·Filed 2020·Granted Apr 13, 2021·26 cites·17 claims
- 0399US10286051B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2017·Granted May 14, 2019·25 cites·15 claims
- 0499US9616114B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0599US8524220B1Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteriaBERMUDES DAVID GORDON·Filed 2011·Granted Sep 3, 2013·62 cites·19 claims
- 0698US10449237B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2017·Granted Oct 22, 2019·17 cites·12 claims
- 0798US9878023B1Protease inhibitor: protease sensitive expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteriaBERMUDES DAVID GORDON·Filed 2015·Granted Jan 30, 2018·19 cites·19 claims
- 0898US9365625B1Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewithBERMUDES DAVID GORDON·Filed 2015·Granted Jun 14, 2016·19 cites·20 claims
- 0998US9068187B1Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteriaBERMUDES DAVID GORDON·Filed 2013·Granted Jun 30, 2015·49 cites·17 claims
- 1098US8771669B1Immunization and/or treatment of parasites and infectious agents by live bacteriaBERMUDES DAVID GORDON·Filed 2011·Granted Jul 8, 2014·45 cites·19 claims
- 1198US8623350B1Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteriaBERMUDES DAVID GORDON·Filed 2012·Granted Jan 7, 2014·38 cites·20 claims
- 1298US8440207B2Live bacterial vaccines for viral infection prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2012·Granted May 14, 2013·41 cites·20 claims
- 1398US7514089B2Genetically modified tumor-targeted bacteria with reduced virulenceVION PHARMACEUTICALS INC·Filed 2005·Granted Apr 7, 2009·52 cites·12 claims
- 1498US7354592B2Genetically modified tumor-targeted bacteria with reduced virulenceVION PHARMACEUTICALS INC·Filed 2005·Granted Apr 8, 2008·63 cites·13 claims
- 1597US11406702B1Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Salmonella as a vaccineBERMUDES DAVID GORDON·Filed 2021·Granted Aug 9, 2022·4 cites·17 claims
- 1697US10828356B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2019·Granted Nov 10, 2020·8 cites·21 claims
- 1797US10729731B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2019·Granted Aug 4, 2020·7 cites·15 claims
- 1897US10087451B2Live bacterial vectors for prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2016·Granted Oct 2, 2018·14 cites·20 claims
- 1997US9593339B1Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatmentBERMUDES DAVID GORDON·Filed 2014·Granted Mar 14, 2017·27 cites·20 claims
- 2097US9486513B1Immunization and/or treatment of parasites and infectious agents by live bacteriaBERMUDES DAVID GORDON·Filed 2014·Granted Nov 8, 2016·17 cites·19 claims
- 2197US9200251B1Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewithBERMUDES DAVID GORDON·Filed 2012·Granted Dec 1, 2015·33 cites·20 claims
- 2297US9200289B1Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteriaBERMUDES DAVID GORDON·Filed 2013·Granted Dec 1, 2015·36 cites·20 claims
- 2397US8647642B2Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2009·Granted Feb 11, 2014·42 cites·18 claims
- 2496US9739773B1Compositions and methods for determining successful immunization by one or more vaccinesBERMUDES DAVID GORDON·Filed 2015·Granted Aug 22, 2017·9 cites·20 claims
- 2596US9657085B1Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteriaBERMUDES DAVID GORDON·Filed 2015·Granted May 23, 2017·9 cites·20 claims
- 2696US8956859B1Compositions and methods for determining successful immunization by one or more vaccinesBERMUDES DAVID G·Filed 2011·Granted Feb 17, 2015·39 cites·20 claims
- 2796US8241623B1Protease sensitivity expression systemBERMUDES DAVID·Filed 2010·Granted Aug 14, 2012·45 cites·20 claims
- 2896US6923972B2Methods for use of genetically modified tumor-targeted bacteria with reduced virulenceUNIV YALE·Filed 2002·Granted Aug 2, 2005·53 cites·23 claims
- 2996US6863894B2Genetically modified tumor-targeted bacteria with reduced virulenceVION PHARMACEUTICALS INC·Filed 2002·Granted Mar 8, 2005·66 cites·25 claims
- 3095US10364435B1Immunization and/or treatment of parasites and infectious agents by live bacteriaBERMUDES DAVID GORDON·Filed 2016·Granted Jul 30, 2019·9 cites·16 claims
- 3195US10188722B2Live bacterial vaccines resistant to carbon dioxide (CO2), acidic pH and/or osmolarity for viral infection prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2016·Granted Jan 29, 2019·12 cites·16 claims
- 3295US9737592B1Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatmentBERMUDES DAVID GORDON·Filed 2015·Granted Aug 22, 2017·21 cites·20 claims
- 3395US9421252B2Live bacterial vaccines resistant to carbon dioxide (CO2), acidic pH and/or osmolarity for viral infection prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2014·Granted Aug 23, 2016·21 cites·16 claims
- 3495US6080849AGenetically modified tumor-targeted bacteria with reduced virulenceVION PHARMACEUTICALS INC·Filed 1997·Granted Jun 27, 2000·116 cites·13 claims
- 3594US9315817B2Live bacterial vaccines for prophylaxis or treatment of infectionAVIEX TECHNOLOGIES LLC·Filed 2013·Granted Apr 19, 2016·24 cites·19 claims
- 3694US7452531B2Compositions and methods for tumor-targeted delivery of effector moleculesVION PHARMACEUTICALS INC·Filed 2005·Granted Nov 18, 2008·51 cites·24 claims
- 3794US6685935B1Vectors for the diagnosis and treatment of solid tumors including melanomaUNIV YALE·Filed 1999·Granted Feb 3, 2004·102 cites·188 claims
- 3894US6447784B1Genetically modified tumor-targeted bacteria with reduced virulenceVION PHARMACEUTICALS INC·Filed 1998·Granted Sep 10, 2002·107 cites·22 claims
- 3994US6190657B1Vectors for the diagnosis and treatment of solid tumors including melanomaUNIV YALE·Filed 1996·Granted Feb 20, 2001·150 cites·66 claims
- 4093US6962696B1Compositions and methods for tumor-targeted delivery of effector moleculesVION PHARMACEUTICALS INC·Filed 2000·Granted Nov 8, 2005·77 cites·9 claims
- 4192US10626403B2Live bacterial vectors for prophylaxis or treatmentBERMUDES DAVID GORDON·Filed 2018·Granted Apr 21, 2020·8 cites·20 claims
- 4292US9597379B1Protease inhibitor combination with therapeutic proteins including antibodiesBERMUDES DAVID GORDON·Filed 2011·Granted Mar 21, 2017·8 cites·12 claims
- 4387US6475482B1Genetically modified tumor-targeted bacteria with reduce virulenceVION PHARMACEUTICALS INC·Filed 1999·Granted Nov 5, 2002·57 cites·14 claims
- 4484US10590185B1Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteriaBERMUDES DAVID GORDON·Filed 2017·Granted Mar 17, 2020·1 cites·20 claims
- 4582US10501746B1Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatmentBERMUDES DAVID GORDON·Filed 2017·Granted Dec 10, 2019·1 cites·12 claims
- 4681US10857233B1Protease inhibitor combination with therapeutic proteins including antibodiesBERMUDES DAVID GORDON·Filed 2017·Granted Dec 8, 2020·1 cites·18 claims
- 4779US10828350B1Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatmentBERMUDES DAVID GORDON·Filed 2017·Granted Nov 10, 2020·2 cites·20 claims
- 4878US12144833B1Copper chelation therapeuticsBERMUDES DAVID GORDON·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 4977US11813295B1Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activityBERMUDES DAVID GORDON·Filed 2020·Granted Nov 14, 2023·0 cites·20 claims
- 5077US11180535B1Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteriaBERMUDES DAVID GORDON·Filed 2017·Granted Nov 23, 2021·1 cites·20 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Gordon Bermudes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →